Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy.
about
Meta-analysis of the acute effects of nicotine and smoking on human performance.Role of progesterone in nicotine addiction: evidence from initiation to relapse.Drug-dependent behaviors and nicotinic acetylcholine receptor expressions in Caenorhabditis elegans following chronic nicotine exposure.The noradrenergic action in antidepressant treatments: pharmacological and clinical aspectsNicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research.Neural bases of pharmacological treatment of nicotine dependence - insights from functional brain imaging: a systematic review.Nicotine dependence and smoking habits in patients with head and neck cancer.Association between cigarette smoking and the vaginal microbiota: a pilot studyVarenicline for tobacco dependence: panacea or plight?Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction.Reinforcer devaluation as a consequence of acute nicotine exposure and withdrawal.The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse controlNicotine reduction revisited: science and future directionsStress-related increases in risk taking and attentional failures predict earlier relapse to smoking in young adults: A pilot investigation.Higher stimulus control is associated with less cigarette intake in daily smokers.Effects of chronic varenicline treatment on nicotine, cocaine, and concurrent nicotine+cocaine self-administration.Pharmacotherapy for smoking cessation: current advances and research topics.Zebrafish models to study drug abuse-related phenotypes.Vaccination against smoking: an annotated agenda for debate. A review of scientific journals, 2001-13.Ear acupressure for smoking cessation: a randomised controlled trial.The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on behavioural responses to nicotine.Longitudinal changes in smoking abstinence symptoms and alternative reinforcers predict long-term smoking cessation outcomes.Transcranial direct current stimulation reduces negative affect but not cigarette craving in overnight abstinent smokersThe dynamics of the urge-to-smoke following smoking cessation via pharmacotherapy.Evaluation of chemically diverse 5-HT₂c receptor agonists on behaviours motivated by food and nicotine and on side effect profiles.Urge to smoke over 52 weeks of abstinence.Progesterone for smoking relapse prevention following delivery: A pilot, randomized, double-blind study.
P2860
Q24621715-21F74275-8017-4EC6-9032-FBB7B2165B31Q24630902-3170A984-94EA-48B3-90F2-F6DB95B911D9Q27307876-D784F072-71E3-4CE8-9C3E-8386204562B7Q28300843-DDD4C5C8-1AD7-41FD-B281-759B5FB5913CQ30244252-603C3E20-8C0A-437E-BAF1-220A741859B6Q30655273-C870D3DF-94E6-46A8-A78F-FD4E1773473EQ33942937-8608E9CD-2A7D-4B45-987B-3D84BEA57280Q34168813-8282A310-CC90-4AB5-B4E6-F7EE6292F210Q34190097-DAAB66B6-EA2C-4C12-8DE1-FBDCAB90014CQ34661063-1E8C94E9-04C2-40F0-B441-6B05907FD78FQ35417501-8B72C66A-435D-46A5-AF0E-7B0E44588732Q35837700-73CE2B74-386D-4F91-8233-57B3B8814E85Q36201699-06A9E0D6-C611-431D-9046-BA563FD6A6F3Q36698090-20260FCD-7F99-4744-AF81-657118ECA76EQ36712127-3B9D4E62-3E58-4048-B228-B63298775DE8Q37642452-04AEA230-B341-49FB-B79B-EB4BED7943E9Q37863092-40DFD5FC-2878-43FC-9424-95D4CCC55604Q37880096-1306B758-FE79-44EC-BD77-771D45858D65Q38216996-83D6299B-716F-4EC1-9DC4-37D2E19B9E42Q39217712-28CCC09B-12F1-444B-9DB3-FA1EBF8A6108Q41052058-6701EB9F-0B02-4F65-8FE4-922D3EF3FB71Q41911418-113FAB21-53AF-413C-B0AF-12BA4E8A464DQ42642241-55F676F4-B272-43CD-8B67-0E8AA1B484F0Q45976682-C22B80CD-71F9-40A4-BBB5-125EA34EAD61Q46240693-3F8777B7-C6A9-4241-8859-C9B0FB543050Q47951783-40D6CD35-A654-4193-B5DE-245D33124920Q48656410-DF48357C-01C7-477D-A867-3339C7B34BC3
P2860
Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Tobacco dependence and withdra ...... rtunities for pharmacotherapy.
@ast
Tobacco dependence and withdra ...... rtunities for pharmacotherapy.
@en
type
label
Tobacco dependence and withdra ...... rtunities for pharmacotherapy.
@ast
Tobacco dependence and withdra ...... rtunities for pharmacotherapy.
@en
prefLabel
Tobacco dependence and withdra ...... rtunities for pharmacotherapy.
@ast
Tobacco dependence and withdra ...... rtunities for pharmacotherapy.
@en
P2860
P1476
Tobacco dependence and withdra ...... rtunities for pharmacotherapy.
@en
P2093
Jack E Henningfield
Saul Shiffman
P2860
P356
10.1016/J.PHARMTHERA.2009.03.011
P577
2009-04-08T00:00:00Z